Issuer: JPMorgan Chase Financial Company LLC, a direct,
wholly owned finance subsidiary of JPMorgan Chase & Co.
Guarantor: JPMorgan Chase & Co.
Index: The MerQube US Large-Cap Vol Advantage Index
(Bloomberg ticker: MQUSLVA). The level of the Index reflects a
deduction of 6.0% per annum that accrues daily.
Contingent Interest Payments: If the notes have not been
automatically called and the closing level of the Index on any
Review Date is greater than or equal to the Interest Barrier, you
will receive on the applicable Interest Payment Date for each
$1,000 principal amount note a Contingent Interest Payment
equal to at least $11.6667 (equivalent to a Contingent Interest
Rate of at least 14.00% per annum, payable at a rate of at least
1.16667% per month) (to be provided in the pricing
supplement).
If the closing level of the Index on any Review Date is less than
the Interest Barrier, no Contingent Interest Payment will be
made with respect to that Review Date.
Contingent Interest Rate: At least 14.00% per annum, payable
at a rate of at least 1.16667% per month (to be provided in the
pricing supplement)
Interest Barrier / Buffer Threshold: 70.00% of the Initial Value
Buffer Amount: 30.00%
Downside Leverage Factor: An amount equal to 1 / (1 - Buffer
Amount), which is 1.42857
Pricing Date: On or about January 23, 2026
Original Issue Date (Settlement Date): On or about January
28, 2026
Review Dates*: February 23, 2026, March 23, 2026, April 23,
2026, May 26, 2026, June 23, 2026, July 23, 2026, August 24,
2026, September 23, 2026, October 23, 2026, November 23,
2026, December 23, 2026, January 25, 2027, February 23,
2027, March 23, 2027, April 23, 2027, May 24, 2027, June 23,
2027, July 23, 2027, August 23, 2027, September 23, 2027,
October 25, 2027, November 23, 2027, December 23, 2027,
January 24, 2028, February 23, 2028, March 23, 2028, April 24,
2028, May 23, 2028, June 23, 2028, July 24, 2028, August 23,
2028, September 25, 2028, October 23, 2028, November 24,
2028, December 26, 2028, January 23, 2029, February 23,
2029, March 23, 2029, April 23, 2029, May 23, 2029, June 25,
2029, July 23, 2029, August 23, 2029, September 24, 2029,
October 23, 2029, November 23, 2029, December 24, 2029,
January 23, 2030, February 25, 2030, March 25, 2030, April 23,
2030, May 23, 2030, June 24, 2030, July 23, 2030, August 23,
2030, September 23, 2030, October 23, 2030, November 25,
2030, December 23, 2030 and January 23, 2031 (final Review
Date)
Interest Payment Dates*: February 26, 2026, March 26, 2026,
April 28, 2026, May 29, 2026, June 26, 2026, July 28, 2026,
August 27, 2026, September 28, 2026, October 28, 2026,
November 27, 2026, December 29, 2026, January 28, 2027,
February 26, 2027, March 29, 2027, April 28, 2027, May 27,
2027, June 28, 2027, July 28, 2027, August 26, 2027,
September 28, 2027, October 28, 2027, November 29, 2027,
December 29, 2027, January 27, 2028, February 28, 2028,
March 28, 2028, April 27, 2028, May 26, 2028, June 28, 2028,
July 27, 2028, August 28, 2028, September 28, 2028, October
26, 2028, November 29, 2028, December 29, 2028, January 26,
2029, February 28, 2029, March 28, 2029, April 26, 2029, May
29, 2029, June 28, 2029, July 26, 2029, August 28, 2029,
September 27, 2029, October 26, 2029, November 28, 2029,
December 28, 2029, January 28, 2030, February 28, 2030,
March 28, 2030, April 26, 2030, May 29, 2030, June 27, 2030,
July 26, 2030, August 28, 2030, September 26, 2030, October
28, 2030, November 29, 2030, December 27, 2030 and the
Maturity Date
Maturity Date*: January 28, 2031
Call Settlement Date*: If the notes are automatically called on
any Review Date (other than the first through fifth and final
Review Dates), the first Interest Payment Date immediately
following that Review Date
* Subject to postponement in the event of a market disruption event and
as described under "Supplemental Terms of the Notes -
Postponement of a Determination Date - Notes Linked Solely to an
Index" in the accompanying underlying supplement and "General Terms
of Notes - Postponement of a Payment Date" in the accompanying
product supplement